SCHEMBL4293142

SCHEMBL4293142

COCCNC(=O)c1n[nH]cc1NC(=O)c1ccccn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.51
KDM4E B2RXH2 2/20 0.51
HTT P42858 1/20 0.51
KDM4C Q9H3R0 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
SMN1; SMN2 Q16637 4/20 0.50
KMT2A Q03164 2/20 0.46
POLB P06746 1/20 0.45
HPGD P15428 1/20 0.45
TP53 P04637 1/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
MAPT P10636 2/20 0.44
PKM P14618 1/20 0.44
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC10 Q969S8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4284474 0.90 GRM4 (0.47) ALDH1A1KDM4EHTTKDM4CL3MBTL1
SCHEMBL4281447 0.90 TSHR (0.51) ALDH1A1KDM4ESMN1; SMN2KMT2AHPGD
SCHEMBL4279961 0.88 KMT2A (0.51) ALDH1A1KDM4EL3MBTL1SMN1; SMN2KMT2A
SCHEMBL4279807 0.87 SMN1; SMN2 (0.49) ALDH1A1KDM4EHTTKDM4CL3MBTL1
SCHEMBL4287145 0.86 SMN1; SMN2 (0.46) ALDH1A1KDM4EHTTKDM4CL3MBTL1
SCHEMBL4279912 0.86 KMT2A (0.51) ALDH1A1KDM4EHTTKDM4CL3MBTL1
SCHEMBL4279804 0.86 SMN1; SMN2 (0.55) ALDH1A1KDM4EHTTKDM4CL3MBTL1
SCHEMBL4281573 0.86 L3MBTL1 (0.49) ALDH1A1KDM4EHTTKDM4CL3MBTL1
SCHEMBL4281575 0.85 RAB9A (0.48) ALDH1A1KDM4EHTTSMN1; SMN2KMT2A
SCHEMBL4290849 0.84 NPC1 (0.47) ALDH1A1SMN1; SMN2KMT2AHPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090156582-A1 Pyrazole Compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-06-18 US disclosed
EP-1847531-A1 PYRAZOLE COMPOUND Takeda Pharmaceutical Company Limited (JP) 2007-10-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156582-A1 Pyrazole Compound GSK3B, GSK3A, GSKIP ALDH1A1 694/4885KDM4E 810/4885HTT 4201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.